| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/07/2004 | CN1144801C Vitreous form known slow-kinin antagonist |
| 04/07/2004 | CN1144800C Indolyl derivatives as 5-hydroxytryptamine medicine |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/07/2004 | CN1144791C Triazole compounds and its application as dopamine-D3-ligands |
| 04/07/2004 | CN1144788C Bicycle vasporession agonists |
| 04/07/2004 | CN1144786C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/07/2004 | CN1144784C Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical composition containing them |
| 04/06/2004 | US6716991 Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation |
| 04/06/2004 | US6716881 Carbanilides used as pesticides |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716870 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 04/06/2004 | US6716866 Aryl-benzimidazole compounds having antiinfective activity |
| 04/06/2004 | US6716859 Anticancer agents |
| 04/06/2004 | US6716857 1-(3-hydrocarbyloxyimino-3-(1-alkyl-1,2,5,6-tetrahydropyrid-3-yl) -alkylpyrrolidin-2-one derivatives; receptivity; analgesics, glaucoma, psychosis, schizophrenia, anxiolytic agents, bipolar disorders; antidepressants; sleep disorders |
| 04/06/2004 | US6716856 Cell proliferative disorders or alzheimer's disease; reduced toxicity; cdk/cyclin kinase inhibitory activity |
| 04/06/2004 | US6716855 Antithrombotic amides |
| 04/06/2004 | US6716851 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof |
| 04/06/2004 | US6716850 Non-nucleoside reverse transcriptase inhibitors |
| 04/06/2004 | US6716847 Antiallergens, antiinflammatory |
| 04/06/2004 | US6716846 High affinity ligands for nociceptin receptor ORL-1 |
| 04/06/2004 | US6716841 Nitrogen containing heterobicycles as factor Xa inhibitors |
| 04/06/2004 | US6716840 Agonists of the melanocortin-4 receptor (?mc-4r?); useful treating obesity and type 2 diabetes |
| 04/06/2004 | US6716839 Inhibitor of factor xa |
| 04/06/2004 | US6716837 Heterocyclic compounds for the treatment of migraine |
| 04/06/2004 | US6716832 Arylphenyl-substituted cyclic ketoenols |
| 04/06/2004 | US6716628 Chondrogenesis promoters and indolin-2-one derivatives |
| 04/06/2004 | US6716257 Oxidation dyes, which are used for treatment of human hair |
| 04/06/2004 | CA2293672C Tricyclic keto amide derivatives useful as farnesyl protein transferase inhibitors |
| 04/06/2004 | CA2124306C Quinazolinone derivatives |
| 04/01/2004 | WO2004026866A1 N-aroyl cyclic amines as orexin receptor antagonists |
| 04/01/2004 | WO2004026864A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/01/2004 | WO2004026859A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026858A1 Substituted heterocyclylpyrimidines |
| 04/01/2004 | WO2004026846A1 Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy |
| 04/01/2004 | WO2004026844A1 Methods and compositions of novel triazine compounds |
| 04/01/2004 | WO2004026843A1 Benzodiazepine derivatives and pharmaceutical compositions containing them |
| 04/01/2004 | WO2004026836A2 1-pyridin-4-yl-urea derivatives |
| 04/01/2004 | WO2004026831A1 2,4-substituted indoles and their use as 5-ht6 modulators |
| 04/01/2004 | WO2004026830A1 2,7-substituted indoles and their use as 5-ht6 modulators |
| 04/01/2004 | WO2004026829A2 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibitors |
| 04/01/2004 | WO2004026828A1 Pyrrole derivatives as antimycobacterial compounds |
| 04/01/2004 | WO2004026827A1 Pyrrolidone derivatives as maob inhibitors |
| 04/01/2004 | WO2004026826A1 4-pyrrolidino-phenyl-benzyl ether derivatives |
| 04/01/2004 | WO2004026825A1 Pyrrolidone derivatives as maob inhibitors |
| 04/01/2004 | WO2004026822A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 04/01/2004 | WO2004026307A1 Triazole derivatives as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026306A2 Pyrazole derivatives as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026305A1 Diaryl ethers as opioid receptor antagonist |
| 04/01/2004 | WO2004026264A2 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 04/01/2004 | WO2004006934A3 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours |
| 04/01/2004 | WO2004006352A3 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/01/2004 | WO2003106425A3 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 04/01/2004 | WO2003099771A3 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003097633A8 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 04/01/2004 | WO2003080596A3 Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides |
| 04/01/2004 | WO2003076408A3 Indazole derivatives that are activators of soluble guanylate cyclase |
| 04/01/2004 | WO2003075853A3 Cyclic derivatives as modulators of chemokine receptor activity |
| 04/01/2004 | WO2003066597A3 Guanidino compounds |
| 04/01/2004 | WO2003063844A3 Treatment of rheumatoid arthritis using imatinie |
| 04/01/2004 | WO2002102314A3 Purine inhibitors of phosphodiesterase (pde) 7 |
| 04/01/2004 | WO2002098852A8 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
| 04/01/2004 | WO2002085897A9 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 04/01/2004 | US20040063959 Esters and amides as PLA2 inhibitors |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063944 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 04/01/2004 | US20040063942 Spiro-indolines as Y5 receptor antagonists |
| 04/01/2004 | US20040063940 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 04/01/2004 | US20040063939 Phosphodiesterase inhibitor |
| 04/01/2004 | US20040063937 Microbiocidal n-phenyl-n-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives |
| 04/01/2004 | US20040063935 Aliphatic nitrogenous five-membered ring compounds |
| 04/01/2004 | US20040063897 Method for the preparation poly(etherimide)s |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063773 Adminstering a pyrrole substituted 2-indolinone compound to a human for the treatment of protein kinase related cellular disorders such as cancer, autoimmune disorders, diabetes, rheumatoid arthritis, angiogenesis and osteoarthritis |
| 04/01/2004 | US20040063772 1-(4-fluoro-3-cyanophenyl)-3-trifluoromethyl-5-pyrazolecarboxylic acid, 1-(4-fluoro-3-cyanophenyl)-3-trifluoromethyl-5-(2-furyl)pyrazole, and imidazole |
| 04/01/2004 | US20040063761 2-(biarylalkyl)amino-3-(fluoroalkanoylamino)pyridine derivatives |
| 04/01/2004 | US20040063758 Alkylating 5-nitroindole with 6-bromohexyl acetate to form a 6-(N-(5-nitroindolyl)) hexyl acetate, hydrolyzing to form alcohol of above ester, estrifying with nicotinic acid, and methylating the intermediate |
| 04/01/2004 | US20040063757 Urotensin-ll receptor antagonists |
| 04/01/2004 | US20040063756 Administering a therapeutically effective amount of 2-Aminoquinolines for the prevention or treatment of eating disorders, weight gain and obesity |
| 04/01/2004 | US20040063755 Aromatic compounds containing hydroxyalkylaminoalkylphenylaminophenyl group; useful for treating pre-term labor, neurological disorders and cardiac disorders |
| 04/01/2004 | US20040063754 Dehalogeno compounds |
| 04/01/2004 | US20040063753 N-acetoamino-4-one-Pyridine derivatives are used as Lp-PLA2 (lipoprotein Associated Phospholipase A2) enzyme inhibitor |
| 04/01/2004 | US20040063749 Excitatory amino acid receptor antagonists |
| 04/01/2004 | US20040063748 Such as 2-(4-amino-2,3,5-trimethylphenoxy)-N-methyl-N-(4-piperidinyl)acetamide which has neuroprotective effects by inducing calcium binding proteins |
| 04/01/2004 | US20040063744 Such as 1-(4-(1-bromo-1-phenyl-methylene)-piperidin-1-yl)-2-(4,7-dimethoxy-6 -azaindol-3-yl)-ethane-1,2-dione for treatment of HIV and acquired immune deficiency syndrome |
| 04/01/2004 | US20040063737 CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents |
| 04/01/2004 | US20040063735 Calcitonin gene related peptide receptor antagonists |
| 04/01/2004 | US20040063733 Quinazoline derivatives |
| 04/01/2004 | US20040063725 Binding neuropeptide Y receptors; hypertension, angina, atherosclerosis, depression, anxiety, inflammation, allergies |
| 04/01/2004 | US20040063724 Neurotransmitter 5-hydroxytryptamine-6 (5-HT6) antagonists |
| 04/01/2004 | US20040063709 Acute and chronic inflammatory disorders; cancer |
| 04/01/2004 | US20040063705 Substituted pyrimidinyl derivatives and methods of use |
| 04/01/2004 | US20040063701 Potent and specific serotonin 2 receptor inhibition with low adverse side effects; such as 1-formyl-N-(2-(4-(5H-dibenzo-(a,d)cyclohepten-5-ylidene)-1 -piperidinyl))ethylisonipecot-amide |
| 04/01/2004 | US20040063698 Inflammatory disorders; such as N-hydroxy-2-(2-(4-(2-methyl-quinolin-4-ylmethoxy)-phenyl)-tetrahydro-furan-2-yl)-acet-amide |
| 04/01/2004 | US20040063691 Preparation and use of imidazole derivatives for treatment of obesity |
| 04/01/2004 | US20040063690 Cardiovascular disorders; guanylate cyclase activation; diseases associated with disturbed cyclic guanosine monophosphate balance |
| 04/01/2004 | US20040063679 Amidino and guanidino peptidyl compounds; autoimmune diseases |
| 04/01/2004 | US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/01/2004 | US20040063645 Such as ((2-(3-guanidino-2-hydroxy-propylcarbamoyl)-1H-indol-5-yl)-amide) |
| 04/01/2004 | US20040063643 Bombesin antagonists |